A Study to Assess the Pharmacokinetics, Tolerability and Safety of the co-Administration of Sancuso (Transdermal Granisetron) and Intravenous Granisetron in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 May 2009
At a glance
- Drugs Granisetron; Granisetron
- Indications Nausea and vomiting
- Focus Pharmacokinetics
- Sponsors ProStrakan
- 05 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 17 Apr 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.